# RHODOS Follow-up Single-visit Study

> **NCT01421381** · — · COMPLETED · sponsor: **Santhera Pharmaceuticals** · enrollment: 60 (actual)

## Conditions studied

- Leber's Hereditary Optic Neuropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01421381
- **Lead sponsor:** Santhera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01421381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01421381, "RHODOS Follow-up Single-visit Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01421381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*